Updated 12 Aug, 2026 22:45
U.S. president Donald Trump ordered national backing for the alleged "gender-affirming care" for minors under 2 major government wellness care programmes.
This decision forms part of a wider process of withdrawal from the transgender policy introduced by erstwhile administrations.
The fresh restrictions will include the Medicaid programme – a joint national and state-level wellness insurance program, designed mainly for low-income Americans – and the CHIP programme, aimed at children from families who do not qualify for Medicaid, but may have difficulty paying private insurance.
“We will not pay to subject our innocent children to these barbarian treatments and practices that origin unimaginable and irreversible harm to their young organisms” – wrote Trump on Tuesday on the fact Social platform.
Restrictions are expected to come into force on 13 October and will include the usage of puberty blockers, other sex hormones and surgical procedures.
Children already undergoing hormonal therapy will benefit from a phase-out period (up to six months) and national intellectual wellness services will be maintained.
Individual states will proceed to be able to finance these procedures from their own resources.
The Centers Agency for Medicare and Medicaid Services (CMS) reported that this decision was the consequence of an analysis carried out by the Department of wellness and Welfare (HHS).
It has shown crucial shortcomings in technological evidence confirming the relevance of medical sex transit in minors and has raised concerns about the possibly irreversible effects of specified actions.
"Children deserve our protection, not experimental interventions that pose serious risks and do not bring proven benefits" – stated CMS chief Mehmet Oz, arguing that stopping national backing will save taxpayers' money and prevent minors from possibly irreversible damage.
The Agency indicated that these procedures may affect risks including fertility, sexual dysfunction and reduced bone density.
Attention has besides been paid to the changing medical guidelines – including the positions of the American Society of Plastic Surgeons (ASPS) and the conclusions of the British Cass Review study – which show limited evidence of benefits for minors and risks outweighing possible advantages.
This step forms part of a wider withdrawal from transgender policy after Trump's return to the office of President.
His administration has taken action to reduce medical transit procedures for minors, to prohibit the participation of transgender athletes in women's competitions and to limit military service opportunities for persons with sex dysphoria.
At least 27 U.S. states have already introduced restrictions on treatment related to sex transit in minors, and respective large hospitals have ceased to execute certain specified treatments in the face of legal challenges, financial force and changing medical guidelines.
Translated by Google Translator
source:https://www.rt.com/news/644175-trump-trans-care-funding-ban/
